"Областное государственное автономное учреждение здравоохранения "Томская областная клиническая больница" (ТОКБ) – это ведущее многопрофильное медицинское учреждение Томской области, одна из крупнейших больниц Сибирского Федерального округа. ОКБ включает в себя консультативно-диагностическую поликлинику, стационар на 1025 коек, в состав которого входит 25 специализированных отделений, отделение экстренной и консультативной медицинской помощи (санавиация), пансионат."

During the past decade, Tomsk Regional Clinical Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 6 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tomsk Regional Clinical Hospital" #1 sponsor was "Celgene" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Bayer" with 2 trials sponsored, "Federal Research Institute of Pediatric Hematology, Oncology and Immunology" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tomsk Regional Clinical Hospital" #1 collaborator was "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tomsk Regional Clinical Hospital" are "Crohn Disease" (3 trials), "Arthritis, Psoriatic" (2 trials), "Childhood Acute Lymphoblastic Leukemia" (2 trials), "Crohn's Disease" (2 trials) and "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Tomsk Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Tomsk Regional Clinical Hospital" are "Drug" (26 trials), "Other" (8 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Ozanimod" (3 trials), "Daunorubicin" (2 trials), "Guselkumab" (2 trials) and "XC221" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tomsk Regional Clinical Hospital" are 28 trials for "All" genders.

Currently, there are NaN active trials in "Tomsk Regional Clinical Hospital". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Tomsk Regional Clinical Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tomsk Regional Clinical Hospital, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".